FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

698805004: Ticagrelor (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2981248017 Ticagrelor (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2981273017 Ticagrelor en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ticagrelor Is a Antiplatelet agent false Inferred relationship Existential restriction modifier
Ticagrelor Is a Nucleoside analog true Inferred relationship Existential restriction modifier
Ticagrelor Is a Substance with platelet aggregation inhibitor mechanism of action (substance) false Inferred relationship Existential restriction modifier
Ticagrelor Has disposition Platelet aggregation inhibitor false Inferred relationship Existential restriction modifier
Ticagrelor Is a Ether false Inferred relationship Existential restriction modifier
Ticagrelor Is a Substance with ether structure true Inferred relationship Existential restriction modifier
Ticagrelor Is a Substance with P2Y12 G-protein-coupled platelet receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Ticagrelor Has disposition P2Y12 G-protein-coupled platelet receptor antagonist true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Product containing ticagrelor Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has basis of strength substance True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing ticagrelor in oral dose form (medicinal product form) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has precise active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Ticagrelor Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing only ticagrelor in oral dose form (medicinal product form) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 60 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release orodispersible tablet (clinical drug) Has precise active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release orodispersible tablet (clinical drug) Has basis of strength substance True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing ticagrelor in oromucosal dose form (medicinal product form) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing only ticagrelor in oromucosal dose form (medicinal product form) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier 1
Ticagrelor adverse reaction Causative agent True Ticagrelor Inferred relationship Existential restriction modifier 1
Ticagrelor adverse reaction Causative agent False Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor allergy Causative agent True Ticagrelor Inferred relationship Existential restriction modifier 1
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (DE Pharmaceuticals) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (DE Pharmaceuticals) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Ethigen Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Ethigen Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Pharmaram Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Pharmaram Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (Pilsco Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (Pilsco Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Mawdsley-Brooks & Company Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (CST Pharma Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (CST Pharma Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (CST Pharma Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (DE Pharmaceuticals) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (DE Pharmaceuticals) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg tablets 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg tablets Has specific active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg tablets Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (AstraZeneca UK Ltd) Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Lexon (UK) Ltd) Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Lexon (UK) Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Lexon (UK) Ltd) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Waymade Healthcare Plc) Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Waymade Healthcare Plc) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg tablets (Waymade Healthcare Plc) 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 60mg tablets Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 60mg tablets Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (AstraZeneca UK Ltd) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 60mg tablets 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 60mg tablets (AstraZeneca UK Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg orodispersible tablets sugar free Has active ingredient False Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg orodispersible tablets sugar free Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) Has active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Ticagrelor 90mg orodispersible tablets sugar free 56 tablet Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier
Brilique 90mg orodispersible tablets (AstraZeneca UK Ltd) 56 tablet 7 x 8 tablets Has specific active ingredient True Ticagrelor Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start